Advertisement
Screener

QUAKER CHEMICAL CORPORATION (KWR) Deferred Income Tax Expense (Benefit)

1.8 / 5 stars · 44/120 Roast Me

QUAKER CHEMICAL CORPORATION Deferred Income Tax Expense (Benefit)

QUAKER CHEMICAL CORPORATION (KWR) reported Deferred Income Tax Expense (Benefit) of -$11.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Cash Flow › Operating Activities

us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-07-30

  • QUAKER CHEMICAL CORPORATION deferred income tax expense (benefit) for the quarter ending 2026-06-30 was -$4.21M.
  • QUAKER CHEMICAL CORPORATION deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$7.52M.
  • QUAKER CHEMICAL CORPORATION deferred income tax expense (benefit) for the quarter ending 2025-12-31 was -$13.93M.
  • QUAKER CHEMICAL CORPORATION deferred income tax expense (benefit) for the quarter ending 2025-09-30 was -$869.00K.
  • QUAKER CHEMICAL CORPORATION deferred income tax expense (benefit) for fiscal 2025 was -$30.43M.
  • QUAKER CHEMICAL CORPORATION deferred income tax expense (benefit) for fiscal 2024 was -$10.03M.
  • QUAKER CHEMICAL CORPORATION deferred income tax expense (benefit) for fiscal 2023 was -$11.44M.
  • QUAKER CHEMICAL CORPORATION deferred income tax expense (benefit) for fiscal 2022 was -$10.55M.
Period endDeferred Income Tax Expense (Benefit) 3 monthDeferred Income Tax Expense (Benefit) 6 monthDeferred Income Tax Expense (Benefit) 9 monthDeferred Income Tax Expense (Benefit) 12 monthDeferred Income Tax Expense (Benefit) 12 month as first filed
2026-06-30-$4.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
-$11.73M
10-Q · filed 2026-07-30
-$25.66M
derived: sum of 3 quarters · filed 2026-07-30
-$26.52M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31-$7.52M
10-Q · filed 2026-04-30
-$21.44M
derived: sum of 2 quarters · filed 2026-04-30
-$22.31M
derived: sum of 3 quarters · filed 2026-04-30
-$34.60M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31-$13.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23
-$14.79M
derived: sum of 2 quarters · filed 2026-02-23
-$27.09M
derived: sum of 3 quarters · filed 2026-07-30
-$30.43M
10-K · filed 2026-02-23
2025-09-30-$869.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
-$13.16M
derived: sum of 2 quarters · filed 2026-07-30
-$16.50M
10-Q · filed 2025-10-30
-$18.60M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30-$12.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
-$15.63M
10-Q · filed 2026-07-30
-$17.73M
derived: sum of 3 quarters · filed 2026-07-30
-$21.94M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31-$3.34M
10-Q · filed 2026-04-30
-$5.44M
derived: sum of 2 quarters · filed 2026-04-30
-$9.64M
derived: sum of 3 quarters · filed 2026-04-30
-$16.54M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31-$2.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23
-$6.30M
derived: sum of 2 quarters · filed 2026-02-23
-$13.20M
derived: sum of 3 quarters · filed 2026-02-23
-$10.03M
10-K · filed 2026-02-23
2024-09-30-$4.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
-$11.10M
derived: sum of 2 quarters · filed 2025-10-30
-$7.93M
10-Q · filed 2025-10-30
2024-06-30-$6.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
-$3.73M
10-Q · filed 2025-07-31
2024-03-31$3.17M
10-Q · filed 2025-05-01
2023-12-31-$11.44M
10-K · filed 2026-02-23
2022-12-31-$10.55M
10-K · filed 2025-02-24
2021-12-31-$12.51M
10-K · filed 2024-02-29
$12.51M
10-K · filed 2022-03-01
2020-12-31-$38.28M
8-K · filed 2023-08-03
$38.28M
10-K · filed 2021-03-01
2019-12-31$24.24M
10-K · filed 2022-03-01
2018-12-31-$8.20M
10-K · filed 2021-03-01
2017-12-31-$3.75M
10-K · filed 2020-03-20
$3.75M
10-K · filed 2018-02-28
2016-12-31-$5.49M
10-K · filed 2019-02-28
$5.49M
10-K · filed 2017-02-28
2015-12-31-$2.40M
10-K · filed 2018-02-28
2014-12-31$1.01M
10-K · filed 2017-02-28
2013-12-31-$30.00K
10-K · filed 2016-02-25
2012-12-31$2.35M
10-K · filed 2015-02-26
2011-12-31$2.43M
10-K · filed 2014-02-28
2010-12-31$1.85M
10-K · filed 2013-03-06
2009-12-31-$505.00K
10-K · filed 2012-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
VALVOLINE INC (VVV)United States$3.618B49.71